Back to Search
Start Over
The discovery of a novel series of compounds with single-dose efficacy against juvenile and adult Schistosoma species
- Source :
- PLoS Neglected Tropical Diseases, PLoS Neglected Tropical Diseases, Vol 15, Iss 7, p e0009490 (2021)
- Publication Year :
- 2021
- Publisher :
- Public Library of Science, 2021.
-
Abstract
- Treatment and control of schistosomiasis depends on a single drug, praziquantel, but this is not ideal for several reasons including lack of potency against the juvenile stage of the parasite, dose size, and risk of resistance. We have optimised the properties of a series of compounds we discovered through high throughput screening and have designed candidates for clinical development. The best compounds demonstrate clearance of both juvenile and adult S. mansoni worms in a mouse model of infection from a single oral dose of < 10 mg/kg. Several compounds in the series are predicted to treat schistosomiasis in humans across a range of species with a single oral dose of less than 5 mg/kg.<br />Author summary Schistosomiasis (also known as Bilharzia) is a severe disease with WHO estimates suggesting that more than 229 million people require preventative treatment. It is caused by parasitic worms which infect through the skin and, when mature, pair up in different parts of the body according to species, and produce eggs leading to significant adverse health impacts including death. Treatment is reliant on one drug, praziquantel, which is effective against adult worms, but has some disadvantages. Praziquantel is not effective against juvenile worms and is therefore unable to prevent the disease. Also, a large dose is required, and furthermore, reliance on one drug risks the development of drug resistance. This research describes the discovery of a new series of potent compounds, unrelated to praziquantel, which kill both the adult and juvenile parasitic worms in vitro, and in mice, following a low single oral dose. Predictions suggest that several of the compounds should be capable of curing infection in people with a single oral dose approximately 10-fold smaller than praziquantel.
- Subjects :
- Male
Schistosoma Mansoni
Physiology
RC955-962
Pharmacology
Biochemistry
Praziquantel
Mice
0302 clinical medicine
Animal Cells
Arctic medicine. Tropical medicine
Drug Discovery
Medicine and Health Sciences
Parasite hosting
media_common
0303 health sciences
biology
Pharmaceutics
Eukaryota
Chemical Synthesis
Animal Models
Lipids
Body Fluids
Infectious Diseases
Blood
Treatment Outcome
Experimental Organism Systems
Liver
Schistosoma
Female
Schistosoma mansoni
Public aspects of medicine
RA1-1270
Anatomy
Cellular Types
medicine.drug
Research Article
Drug
media_common.quotation_subject
030231 tropical medicine
Schistosomiasis
Mouse Models
Research and Analysis Methods
Blood Plasma
Drug Administration Schedule
03 medical and health sciences
Schistosomicides
Dose Prediction Methods
Model Organisms
Helminths
medicine
Potency
Juvenile
Animals
Humans
030304 developmental biology
Plasma Proteins
Public Health, Environmental and Occupational Health
Organisms
Biology and Life Sciences
Proteins
Cell Biology
biology.organism_classification
medicine.disease
Invertebrates
Schistosomiasis mansoni
Animal Studies
Hepatocytes
Zoology
Oils
Schistosoma species
Subjects
Details
- Language :
- English
- ISSN :
- 19352735 and 19352727
- Volume :
- 15
- Issue :
- 7
- Database :
- OpenAIRE
- Journal :
- PLoS Neglected Tropical Diseases
- Accession number :
- edsair.doi.dedup.....df3621d17fb61a7ad1bc66fee8729daa